Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications
dc.creator | Olloquequi J. | |
dc.creator | Cornejo-Córdova E. | |
dc.creator | Verdaguer E. | |
dc.creator | Soriano F.X. | |
dc.creator | Binvignat O. | |
dc.creator | Auladell C. | |
dc.creator | Camins A. | |
dc.date.accessioned | 2020-09-02T22:24:48Z | |
dc.date.accessioned | 2022-11-08T20:25:58Z | |
dc.date.available | 2020-09-02T22:24:48Z | |
dc.date.available | 2022-11-08T20:25:58Z | |
dc.date.created | 2020-09-02T22:24:48Z | |
dc.date.issued | 2018 | |
dc.identifier | 32, 3, 265-275 | |
dc.identifier | 02698811 | |
dc.identifier | https://hdl.handle.net/20.500.12728/5651 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5145883 | |
dc.language | en | |
dc.publisher | SAGE Publications Ltd | |
dc.subject | Alzheimer’s disease | |
dc.subject | autism spectrum disorder | |
dc.subject | depression | |
dc.subject | Glutamate | |
dc.subject | stroke | |
dc.subject | acetylcysteine | |
dc.subject | calcium ion | |
dc.subject | cycloserine | |
dc.subject | fludrocortisone | |
dc.subject | free radical | |
dc.subject | glutamate receptor | |
dc.subject | glutamic acid | |
dc.subject | ketamine | |
dc.subject | memantine | |
dc.subject | n methyl dextro aspartic acid receptor blocking agent | |
dc.subject | neu 2000kwl | |
dc.subject | riluzole | |
dc.subject | tissue plasminogen activator | |
dc.subject | unclassified drug | |
dc.subject | ursodeoxycholic acid | |
dc.subject | glutamate receptor | |
dc.subject | glutamic acid | |
dc.subject | Alzheimer disease | |
dc.subject | amyotrophic lateral sclerosis | |
dc.subject | autism | |
dc.subject | brain ischemia | |
dc.subject | cell death | |
dc.subject | depression | |
dc.subject | disorders of mitochondrial functions | |
dc.subject | drug targeting | |
dc.subject | excitotoxicity | |
dc.subject | human | |
dc.subject | mental disease | |
dc.subject | neurologic disease | |
dc.subject | nonhuman | |
dc.subject | oxidative stress | |
dc.subject | Parkinson disease | |
dc.subject | pathogenesis | |
dc.subject | priority journal | |
dc.subject | Review | |
dc.subject | schizophrenia | |
dc.subject | signal transduction | |
dc.subject | animal | |
dc.subject | mental disease | |
dc.subject | metabolism | |
dc.subject | nerve cell | |
dc.subject | neurologic disease | |
dc.subject | pathology | |
dc.subject | Animals | |
dc.subject | Glutamic Acid | |
dc.subject | Humans | |
dc.subject | Mental Disorders | |
dc.subject | Nervous System Diseases | |
dc.subject | Neurons | |
dc.subject | Receptors, Glutamate | |
dc.title | Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications | |
dc.type | Review |